PAKISTAN'S PERSPECTIVE ON COVID-19 VACCINES

ABSTRACT

There has never been a pandemic of this magnitude in contemporary human history. In less than 16 months after the outbreak of the pandemic, almost 188 million confirmed COVID-19 cases and 2.5 million fatalities have been reported globally. In addition, a great deal of work has been done to discover vaccinations that are both safe and effective. In May 2021, 184 SARS-Cov-2 vaccine contestants were in pre-clinical trials, 105 were in clinical trials, and 18 vaccines had been licensed for emergency use by at least one national or international regulatory body. Till date, only 5 vaccines are given approval by WHO for emergency use that includes, Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. These vaccines include entire virus inactivated or live attenuated, virus vector, protein-based, and nucleic acid vaccines. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan's perspective towards COVID-19 vaccines with an updated review.